Cells can be rejuvenated and biological clocks reset using cellular reprogramming. A growing number of companies now aim to use cellular reprogramming to develop therapies for rejuvenating human beings. Can the ‘young’ science of rejuvenation, currently mostly based on in vitro studies, drive a new biotech field toward clinical applications?
Bibliographical noteFunding Information:
Work in the lab of J.P.M. is supported by grants from the Wellcome Trust (208375/Z/17/Z), LongeCity, and the Biotechnology and Biological Sciences Research Council (BB/R014949/1 and BB/V010123/1). J.P.M. is an advisor/consultant for the Longevity Vision Fund, Centaura, NOVOS, YouthBio Therapeutics and the founder of Magellan Science Ltd, a company providing consulting services in longevity science. A.O. is founder of Longevity Consultancy Group, a company providing consulting services in longevity science.
© 2022 Elsevier Ltd
- Yamanaka factors
- gene therapy
ASJC Scopus subject areas